EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Toward Artificial Intelligence in Oncology and Cardiology: A Narrative Review of Systems, Challenges, and Opportunities

Visar Vela iD, Ali Yasin Sonay iD, Perparim Limani iD, Lukas Graf, Besmira Sabani, Diona Gjermeni, Andi Rroku iD, Arber Zela, Era Gorica, Hector Rodriguez Cetina Biefer iD, Uljad Berdica iD, Euxhen Hasanaj iD und 3 weitere

Journal of Clinical Medicine · 24.10.2025 · 14 (21) · 7555

DOI: 10.3390/jcm14217555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.10.2025. Verfasst von Visar Vela und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre Suisse de Contrôle de Qualité, 1225 Geneva, Switzerland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Artificial intelligence (AI), the overarching field that includes machine learning (ML) and its subfield deep learning (DL), is rapidly transforming clinical research by enabling the analysis of high-dimensional data and automating the output of diagnostic and prognostic tests. As clinical trials become increasingly complex and costly, ML-based approaches (especially DL for image and signal data) offer promising solutions, although they require new approaches in clinical education.

Objective

Explore current and emerging AI applications in oncology and cardiology, highlight real-world use cases, and discuss the challenges and future directions for responsible AI adoption.

Methods

This narrative review summarizes various aspects of AI technology in clinical research, exploring its promise, use cases, and its limitations. The review was based on a literature search in PubMed covering publications from 2019 to 2025. Search terms included “artificial intelligence”, “machine learning”, “deep learning”, “oncology”, “cardiology”, “digital twin”. and “AI-ECG”. Preference was given to studies presenting validated or clinically applicable AI tools, while non-English articles, conference abstracts, and gray literature were excluded.

Results

AI demonstrates significant potential in improving diagnostic accuracy, facilitating biomarker discovery, and detecting disease at an early stage. In clinical trials, AI improves patient stratification, site selection, and virtual simulations via digital twins. However, there are still challenges in harmonizing data, validating models, cross-disciplinary training, ensuring fairness, explainability, as well as the robustness of gold standards to which AI models are built.

Conclusions

The integration of AI in clinical research can enhance efficiency, reduce costs, and facilitate clinical research as well as lead the way towards personalized medicine. Realizing this potential requires robust validation frameworks, transparent model interpretability, and collaborative efforts among clinicians, data scientists, and regulators. Interoperable data systems and cross-disciplinary education will be critical to enabling the integration of scalable, ethical, and trustworthy AI into healthcare.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencecardiologyclinical diagnosticsdeep learningmachine learningoncology

Autor:innen und Institutionen

  • Centre Suisse de Contrôle de Qualité, 1225 Geneva, Switzerland.
  • Epistudia, 3008 Bern, Switzerland.
  • Department of Visceral Surgery and Transplantation, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Center for Laboratory Medicine, Hemostasis and Hemophilia Center, 9008 St. Gallen, Switzerland.
  • Institute of Chemistry and Biotechnology, Zurich University of Applied Sciences (ZHAW), 8820 Wädenswil, Switzerland.
  • Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, 79085 Freiburg, Germany.

ORCID-Profile: Visar Vela, Ali Yasin Sonay, Perparim Limani, Andi Rroku, Hector Rodriguez Cetina Biefer, Uljad Berdica, Euxhen Hasanaj, Taulant Muka, Omer Dzemali

Zitieren

APA

Vela, V., Sonay, A. Y., Limani, P., Graf, L., Sabani, B., Gjermeni, D., Rroku, A., Zela, A., Gorica, E., Rodriguez Cetina Biefer, H., Berdica, U., Hasanaj, E., Trnjanin, A., Muka, T., & Dzemali, O. (2025). Toward Artificial Intelligence in Oncology and Cardiology: A Narrative Review of Systems, Challenges, and Opportunities. Journal of Clinical Medicine, 14(21), 7555. https://doi.org/10.3390/jcm14217555

Vancouver

Vela V, Sonay AY, Limani P, Graf L, Sabani B, Gjermeni D, et al. Toward Artificial Intelligence in Oncology and Cardiology: A Narrative Review of Systems, Challenges, and Opportunities. Journal of Clinical Medicine. 2025;14(21):7555. doi:10.3390/jcm14217555

BibTeX
@article{Vela2025,
  author = {Vela, Visar and Sonay, Ali Yasin and Limani, Perparim and Graf, Lukas and Sabani, Besmira and Gjermeni, Diona and Rroku, Andi and Zela, Arber and Gorica, Era and Rodriguez Cetina Biefer, Hector and Berdica, Uljad and Hasanaj, Euxhen and Trnjanin, Adisa and Muka, Taulant and Dzemali, Omer},
  title = {Toward Artificial Intelligence in Oncology and Cardiology: A Narrative Review of Systems, Challenges, and Opportunities},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {21},
  pages = {7555},
  doi = {10.3390/jcm14217555}
}
Kostenlos starten →